Source link : https://newshealth.biz/health-news/acc-revises-obesity-control-strategies-in-heart-failure/
A new Scientific Statement from the American College of Cardiology (ACC) has named two anti-obesity drugs as options for symptom control in patients with heart failure. The benefit for these incretin mimics, semaglutide and tirzepatide, is attributed to symptom control, according to the statement. The document, published on June 13 in the Journal of the […]
The post ACC Revises Obesity Control Strategies in Heart Failure first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-20 06:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8